[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337890-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337890-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exploring-molecular-targets-herbal-isolatesin-cervical-cancer-therapy","Exploring molecular targets: herbal isolatesin cervical cancer therapy","","Cervical cancer remains a major global health burden, with limited progress for recurrent disease despite incremental chemotherapy gains. This study investigates molecular targeted therapy opportunities by examining previously reported herbal compounds—epicatechin, curcumin, myricetin, jatrorrhizine, and arborinine—within cervical cancer. Differentially expressed genes are identified via a systems biology workflow, followed by protein–protein interaction analysis, survival association testing, and evaluation of herbal binding to prognostic regulators.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exploring-molecular-targets-herbal-isolatesin-cervical-cancer-therapy/337890/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exploring-molecular-targets-herbal-isolatesin-cervical-cancer-therapy/337890.png","ImageObject",300,407,{"name":42,"@type":43},"Maeve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What therapeutic approach does the study focus on for cervical cancer?","Question",{"text":63,"@type":64},"It focuses on molecular targeted therapy, evaluating how herbal isolates could act on key molecular regulators involved in cervical cancer progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were molecular targets identified in the study?",{"text":68,"@type":64},"The study used a systems biology approach to find differentially expressed genes in cervical cancer tissues, built a protein–protein interaction network, and extracted central prognostic genes.",{"name":70,"@type":61,"acceptedAnswer":71},"Which herbal compound showed strong binding evidence, and where?",{"text":72,"@type":64},"Molecular docking indicated robust binding affinity between myricetin and the CEBPD DNA binding site.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337890,1790798529,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Ahmadi etal. Genomics & Informatics (2024) 22:9 [https://doi.org/10.1186/s44342-024-00008-1](https://doi.org/10.1186/s44342-024-00008-1)  \nGenomics & Informatics  \n RESEARCH Open Access  \nExploring molecular targets: herbal isolatesin cervical cancer therapy  \nMaryam Ahmadi1 , Razieh Abdollahi1 , Marzieh Otogara2 and Amir Taherkhani3*  \nAbstract  \nObjective Cervical cancer (CxCa) stands as a significant global health challenge, ranking fourth in cancer-related mortality among the female population. While chemotherapy regimens have demonstrated incremental progress in extending overall survival, the outlook for recurrent CxCa patients remains disheartening. An imperative necessity arises to delve into innovative therapeutic avenues, with molecular targeted therapy emerging as a promising candidate. Previous investigations have shed light on the therapeutic effectiveness of five distinct herbal compounds, epicatechin, curcumin, myricetin, jatrorrhizine, and arborinine, within the context of CxCa.  \nMethods A systems biology approach was employed to discern differentially expressed genes (DEGs) in CxCa tissues relative to healthy cervical epithelial tissues. A protein–protein interaction network (PPIN) was constructed, anchored in the genes related to CxCa. The central genes were discerned within the PPIN, and Kaplan–Meier survival curves explored their prognostic significance. An assessment of the binding affinity of the selected herbal compounds to the master regulator of prognostic markers in CxCa was conducted.  \nResults A significant correlation between the overexpression of MYC, IL6, JUN, RRM2, and VEGFA and an adverse prognosis in CxCa was indicated. The regulation of these markers is notably influenced by the transcription factor CEBPD. Molecular docking analysis indicated that the binding affinity between myricetin and the CEBPD DNA binding site was robust.  \nConclusion The findings presented herein have unveiled pivotal genes and pathways that play a central role in the malignant transformation of CxCa. CEBPD has emerged as a potential target for harnessing the therapeutic potential of myricetin in this context.  \nKeywords Cervical cancer, Drug, Pathogenesis, Pathway, Prognosis, Target  \n*Correspondence:  \nAmir Taherkhani [amir.007.taherkhani@gmail.com](amir.007.taherkhani@gmail.com)  \n1 Clinical Research Development Unit of Fatemiyeh Hospital, Department of Gynecology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran  \n2 Mother and Child Care Research Center, Hamadan University of Medical Sciences, Hamadan, Iran  \n3 Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran  \n1 Introduction  \nCervical cancer (CxCa) is ranked fourteenth among all cancers and the fourth-ranked cancer among women worldwide [1]. The prevalence of cervical cancer remains significant globally, with an estimated 604,127 cases and 341,831 deaths in 2020 [2]. The age-standardized incidence rate was 13.3 cases per 100,000 women-years, and the mortality rate was 7.2 deaths per 100,000 womenyears. There are substantial geographical and socioeconomic inequalities in cervical cancer incidence and mortality, with higher rates in countries with lower levels of human development [2]. In the UK, there has been a decline in cervical cancer incidence due to the national  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your i","cbCaijbatvlaGfpc","https://ap.wps.com/l/cbCaijbatvlaGfpc","pdf",4540551,16,"English","# Abstract\n# Objective\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What therapeutic approach does the study focus on for cervical cancer?\",\"answer\":\"It focuses on molecular targeted therapy, evaluating how herbal isolates could act on key molecular regulators involved in cervical cancer progression.\"},{\"question\":\"How were molecular targets identified in the study?\",\"answer\":\"The study used a systems biology approach to find differentially expressed genes in cervical cancer tissues, built a protein–protein interaction network, and extracted central prognostic genes.\"},{\"question\":\"Which herbal compound showed strong binding evidence, and where?\",\"answer\":\"Molecular docking indicated robust binding affinity between myricetin and the CEBPD DNA binding site.\"}]","Exploring molecular targets: herbal isolatesin cervical cancer therapy | PDF",1790021078,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39fbecf4a123fadda79e7d7eff4614f3.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/527cb21c761e9f66661f960748db7b3e.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/180b97f0c8744ab3f38a1053a24bfbcb.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/105a6a4001443640035d02316e0a2835.webp",980,1301]